Like I said, its used in plenty of medications
Food and Drug Administration (FDA), compounded medications are not approved by the FDA for quality, safety, or effectiveness
The broader concern about unapproved growth hormone peptides Eric Topol, writing in Ground Truths in July 2025, grouped ipamorelin with CJC-1295 and tesamorelin as growth hormone related peptides that "carry the potential risk of cancer" on mechanistic grounds, through IGF-1 elevation and broad cell growth signalling [4]
This peptide does not affect lean muscle or bone growth, focusing solely on adipose tissue reduction
It would also help explain a clinical observation discussed later: the gastrointestinal side effects associated with amylin analogs (nausea, early fullness) tend to be most pronounced during dose escalation and to ease with continued treatment, a pattern consistent with partial adaptation of the very gastric mechanism in question